Fenglin Hu

412 total citations
14 papers, 306 citations indexed

About

Fenglin Hu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Fenglin Hu has authored 14 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Fenglin Hu's work include Pancreatitis Pathology and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Phagocytosis and Immune Regulation (3 papers). Fenglin Hu is often cited by papers focused on Pancreatitis Pathology and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Phagocytosis and Immune Regulation (3 papers). Fenglin Hu collaborates with scholars based in China and United States. Fenglin Hu's co-authors include Dong Shang, Hong Xiang, Fangyue Guo, Juying Jiao, Guan‐Hu Bao, Yunfei Zhu, Guo‐Wei Qin, Qi Zhou, Qi Zhou and Liang Zhao and has published in prestigious journals such as Molecules, RSC Advances and Journal of Food Science.

In The Last Decade

Fenglin Hu

12 papers receiving 298 citations

Peers

Fenglin Hu
Comparison fields: 5 of 73
  • Surgery 154
  • Molecular Biology 116
  • Oncology 90
  • Immunology 80
  • Epidemiology 31
Replace Juying Jiao with:
Juying Jiao China
Beili Xi China
Sapana Bansod India
Ken Tsuboi Japan
Kunlin Wu China
R. Jason Kirby United States
Haidong Bao China
Hiroki Manabe Japan
Shi Dong China
S. Murthy United States
Juying Jiao China View profile →
Citations per field, relative to Fenglin Hu
Fenglin Hu · 1×
Citations per year, relative to Fenglin Hu
Fenglin Hu · 1×

Countries citing papers authored by Fenglin Hu

Since Specialization
Citations

This map shows the geographic impact of Fenglin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglin Hu more than expected).

Fields of papers citing papers by Fenglin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglin Hu. The network helps show where Fenglin Hu may publish in the future.

Co-authorship network of co-authors of Fenglin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglin Hu. A scholar is included among the top collaborators of Fenglin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglin Hu. Fenglin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
# Work Indexed citations
1 0
2 0
3 10
4 24
5 119
6
IL-17 in pancreatic disease: pathogenesis and pharmacotherapy.
14
7 7
8
LncRNA-PVT1 aggravates severe acute pancreatitis by promoting autophagy via the miR-30a-5p/Beclin-1 axis.
22
9 20
10 15
11 23
12 38
13 1
14 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026